Patient Research
Find a studySpecialtiesConditionsTreatmentsBy countryLearn
Sign in
Research.Patient.info

Myelodysplastic syndromes, Dysplastic chronic myelomonocytic leukaemia research hub

1 indexed studies · 1 currently recruiting

  • recruitingPhase I and Phase II (Integrated)- First administration to humans

    A Modular Phase I/II, Open-label, Multicentre Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of AZD2962, an IRAK4 inhibitor, as Monotherapy and in Combination with other Agents, in Participants with Hematologic Neoplasms

    This clinical trial is testing a new medicine called AZD2962 for adults with rare blood conditions, such as myelodysplastic syndromes (MDS) and chronic myelomonocytic leukaemia (CMML). Researchers want to find safe doses, monitor any side effects, and see if the treatment helps control abnormal blood cell growth.

    Spain
Advertisement
Advertisement
Advertisement
Patient.info Research

Find clinical research studies and trials explained in plain English - powered by Patient.info.

About
  • About us
  • Advertise with us
  • Partnerships
  • Authors
  • Contact us
Research explained
  • What is a clinical trial?
  • Trial phases explained
  • Why volunteer?
  • Clinical research FAQ
  • All health-research articles
Legal
  • About our content
  • Report a correction
  • Accessibility statement
  • Cookie policy
  • Privacy policy
  • Terms of use
  • Editorial policy
Find a study

Search clinical research studies and trials by condition, location and eligibility.

Browse studies →Learn about trials →
Information only. Research.Patient.info surfaces public clinical-trial registry data and explains it in plain English. We are not affiliated with the MHRA, HRA, NHS, NIHR or any regulator. Inclusion of a study is not an endorsement and is not medical advice — always discuss with your own doctor before agreeing to take part. See about our content or report a correction.
© 2026 Navigate Health Ltd. All rights reserved.
Registered number: 16229589
Registered office: 128 City Road, London, United Kingdom, EC1V 2NX.
Patient is a UK registered trade mark.
Patient does not provide medical advice, diagnosis or treatment.